Breaking News

Fresenius Kabi Launches Levofloxacin Freeflex IV

Designed for easier handling with enhanced safety

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fresenius Kabi USA has launched Levofloxacin in 5% Dextrose Injection in freeflex containers. Freeflex is designed for infusion solutions and has been marketed globally since 2005. Freeflex has multilayer polyolefin film that is PVC-free, plasticizer-free, non-DEHP, and is designed for easier handling with enhanced safety, and environmental performance.   Levofloxacin is a fluoroquinolone antibacterial indicated for use in the treatment of bacterial infections caused by susceptible bacteria, inc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters